The global veterinary rapid test market size is anticipated to reach USD 1.85 billion by 2030, and it is projected to grow at a CAGR of 12.33% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing animal population and ownership rates, elevated spending on animals, a heightened emphasis on preventive healthcare for animals, advancements in veterinary rapid test kits, and rising adoption of pet insurance. Pets are commonly found in homes everywhere, including in the UK. According to the article published by Pet Keen in 2024 stated that the pet population in the UK in 2021 was estimated to be 12.5 million dogs & 12.2 million cats. As more households adopt companions into their homes, there's an increased demand for efficient and accessible healthcare solutions. This surge in pet ownership drives the need for rapid test kits in veterinary practices, as pet owners increasingly seek convenient and timely diagnostic tools to ensure the health and well-being of their pets.
The market for these diagnostic kits will see a steady positive outlook due to the high prevalence of Urinary Tract Infections (UTIs) among companion animals in the country. One of the most common diagnoses in companion animal illnesses is bacterial UTI, which is the main cause of antibiotic prescriptions. According to data on the prevalence of uropathogens in cats and dogs from Germany published in the Antibiotics Journal in 2022, uropathogenic growth was found in 38.5% of cat samples and 43.9% of dog samples. Furthermore, Escherichia coli (48.4%) was the most common pathogen recovered, followed by Coagulase-positive Staphylococci (CoPS; 11.5%) and Enterococcus spp. (11.9%).
In addition, the expansion of product launches by key players is propelling growth in the veterinary rapid test kit market. These new products address emerging needs in veterinary medicine. For instance, in October 2023, Zoetis launched the Basepaws Breed + Health Dog DNA Test.This innovative test enables pet owners to shift from a reactive to a proactive approach in pet care, thanks to its simple swabbing process and results tailored for mobile devices. This product marks a significant leap forward in empowering pet owners to take a more proactive role in their dogs' health through accessible and user-friendly genetic testing.
Request a free sample copy or view report summary: Veterinary Rapid Test Market Report
Based on product, the test kits segment led the market with a largest revenue share of 80% in 2023 and is expected to grow at the fastest CAGR of 12.53% during forecast period due to an increase in technological advancements in veterinary diagnostic tests
Based on animal type, the companion animals segment held the market with largest revenue share in 2023 and is projected to grow at fastest CAGR during the forecast period, owing to a surge in pet population and high pet spending
In terms of technology, the immunoassays segment led the market with largest revenue share in 2023. The PCR technology segment is projected to grow at the fastest CAGR during forecast period. The Immunoassay-based rapid test kits are available for the detection of various veterinary pathogens and conditions, such as infectious diseases in companion animals (e.g., canine parvovirus & feline leukaemia virus) and livestock (e.g., bovine viral diarrhea virus & avian influenza virus)
Based on testing category, the virology segment held the market with the largest revenue share in 2023, due to growing government’s initiatives to implement preventive healthcare programs to reduce the spread of viral diseases among animals. On other hand, the parasitology segment is estimated to grow at fastest CAGR during forecast period, due to increasing prevalence of parasitic infections in companion & production animals and the availability of various test kits
Based on end-use, the veterinary hospitals & clinics segment held the market with the largest revenue share in 2023, owing to the increasing demand for diagnostics and readily accessible advanced diagnostic technologies in hospitals. The home setting segment is estimated to grow at fastest CAGR in the forecast period
North America dominated the market with the revenue share of 36% in 2023. Conversely, Asia Pacific region is anticipated to grow fastest CAGR of 14.40% in forecast period
Advances in rapid diagnostic technology led to development of more accurate, user-friendly, and cost-effective veterinary rapid test kits. Such advancements are expected to drive market growth
Grand View Research has segmented the global veterinary rapid test market based on product, animal type, technology, testing category, end-use, and region:
Veterinary Rapid Test Product Outlook (Revenue, USD Million, 2018 - 2030)
Test Kits
Readers
Veterinary Rapid Test Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Companion Animal
Dogs
Cats
Horses
Other Companion Animals
Production Animal
Cattle
Poultry
Swine
Other Production Animals
Veterinary Rapid Test Technology Outlook (Revenue, USD Million, 2018 - 2030)
Immunoassays
PCR
Veterinary Rapid Test Testing Category Outlook (Revenue, USD Million, 2018 - 2030)
Virology
Parasitology
Bacteriology
Clinical Chemistry
Other Categories
Veterinary Rapid Test End-Use Outlook (Revenue, USD Million, 2018 – 2030)
Veterinary Hospitals & Clinics
Homecare Settings
Other End Use
Veterinary Rapid Test Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Veterinary Rapid Test Market
Zoetis
IDEXX Laboratories, Inc.
Virbac
Heska Corporation (Mars Inc.)
Thermo Fisher Scientific
Neogen Corporation
Prometheus Bio Inc.
Fassisi GmbH
Biopanda Reagents Ltd
Boster Biological Technology.
"The quality of research they have done for us has been excellent..."